Comparison of treatment of severe rheumatoid arthritis patients with biological agents and JAK-STAT inhibitors. An extension study
Introduction This study compared treatment with biologic agents and Janus kinase inhibitors (JAKi) in combination with methotrexate (MTX) for rheumatoid arthritis (RA) in a real-world setting at a large center in Poland. There is a persistent shortage of such studies, and illustrating the switching...
Saved in:
Main Author: | Małgorzata Wisłowska |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2024-11-01
|
Series: | Rheumatology |
Subjects: | |
Online Access: | https://reu.termedia.pl/Comparison-of-treatment-of-severe-rheumatoid-arthritis-patients-with-biological-agents,194686,0,2.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted Therapy for Rheumatoid Arthritis in the New Era
by: WANG Jun, et al.
Published: (2025-01-01) -
Advances in the Drugs Treatment of Psoriatic Arthritis
by: LU Chaofan, et al.
Published: (2024-12-01) -
Efficacy and safety of conventional synthetic, biologic, and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis-interstitial lung disease: A narrative review
by: Richard Conway, et al.
Published: (2021-01-01) -
Recent evidence comparing combination of conventional synthetic disease-modifying antirheumatic drugs with biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
by: Abhishek Zanwar, et al.
Published: (2017-01-01) -
Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India
by: Keerthi Talari, et al.
Published: (2021-01-01)